Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.
RECRUITINGINTERVENTIONAL

Effect of Diluent Volume on Colistin Inhalation Therapy

Effect of Diluent Volume on Colistin Inhalation Therapy for Mechanically Ventilated Respiratory Patients

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The aim of this study is to investigate the impact of different diluent volumes for the same dosage of colistin in mechanically ventilated respiratory patients receiving colistin inhalation therapy. The study aims to determine whether the diluent volume has an effect on clinical outcomes, including ICU length of stay, total hospitalization duration, duration of respiratory support within 28 days, mortality rates within 28 days and 90 days, as well as analyze the pharmacokinetic profile of colistin in blood and bronchoalveolar lavage fluid. Additionally, the study will evaluate the incidence of nebulizer malfunctions and blockages. The findings of this research will help identify the optimal diluent volume for colistin inhalation therapy in clinical practice.

Who May Be Eligible (Plain English)

Who May Qualify: - Admitted to the Intensive Care Unit. - Age greater than 18 years and using a ventilator due to acute respiratory failure. - Requires inhalation colistin treatment as determined by the disease. - Sign the written willing to sign a consent form form. Who Should NOT Join This Trial: - Renal failure requiring renal dialysis. - Receiving both inhaled colistin and intravenous colistin treatments. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: * Admitted to the Intensive Care Unit. * Age greater than 18 years and using a ventilator due to acute respiratory failure. * Requires inhalation colistin treatment as determined by the disease. * Sign the written informed consent form. Exclusion Criteria: * Renal failure requiring renal dialysis. * Receiving both inhaled colistin and intravenous colistin treatments.

Treatments Being Tested

OTHER

Colistin 1 MU in normal saline 1 ml

Colistin 1 MU diluted in normal saline 1 ml, total volume of 12 ml

OTHER

Colistin 1 MU in normal saline 2 ml

Colistin 1 MU diluted in normal saline 2 ml, total volume of 12 ml

Locations (1)

Fu Jen Catholic University Hospital, Fu Jen Catholic University
New Taipei City, Taiwan